Company Overview
Snapshot
Founded in August 2017 by Arnon Chait and Roi Feingersch, Foresee Genomics operates with 1–10 employees. The company has raised $2.1 million across 4 funding rounds from 3 investors.
Business overview
Foresee Genomics is a Health Tech & Life Sciences company developing a DNA testing system for cancer patients. Its core technology combines molecular biology and computational analysis to provide physicians with genetic data for treatment decisions. The company's tests are designed to be performed at the point of care in hospitals or local clinics, utilizing a nanopore sequencing platform for accurate and affordable genomic diagnostics. Foresee Genomics operates in the Digital Medical Diagnostics sector, serving healthcare providers, clinics, and hospitals with solutions for oncology, hematology, and genetic disorders.
Log in to access full profile ›Company Intelligence Q&A
- What is Foresee Genomics' primary focus?
- Foresee Genomics is focused on developing a DNA testing system for cancer patients, combining molecular biology and computational analysis to provide genetic data for treatment decisions.
- When was Foresee Genomics founded and by whom?
- Foresee Genomics was founded in August 2017 by Arnon Chait and Roi Feingersch.
- What type of non-equity funding did Foresee Genomics receive?
- In December 2017, Foresee Genomics received a grant from the Israel Innovation Authority.